Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length

Immunology

Volumn 119, Issue 2, 2006, Pages 243-253

  Wallace, Diana L ^a   Bérard, Marion ^b   Soares, Maria V D ^c   Oldham, Janine ^a   Cook, Joanne E ^d   Akbar, Arne N ^d   Tough, David F ^a   Beverley, Peter C L ^a  

^a EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD8 T cell; Cytokine; Telomere

Indexed keywords

CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 7;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; TELOMERE;

ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; INTERLEUKIN-7; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS; TELOMERASE; TELOMERE;

EID: 33748750775     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02429.x     Document Type: Article

References (41)

1. Beverley PC. Kinetics and clonality of immunological memory in humans. Semin Immunol 2004; 16:315-21.
2. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
3. Hulstaert F, Hannet I, Deneys V, Munhyeshuli V, Reichert T, De Bruyere M, Strauss K. Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 1994; 70:152-8.
4. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994; 179:1127-35.
5. Macallan DC, Asquith B, Irvine AJ et al. Measurement and modeling of human T cell kinetics. Eur J Immunol 2003; 33:2316-26.
6. Fagnoni F, F0 Vescovini R, Passeri G et al. Shortage of circulating naive CD8 (+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95:2860-8.
7. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169:1984-92.
8. Dunne PJ, Faint JM, Gudgeon NH et al. Epstein-Barr virus-specific CD8 (+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 2002; 100:933-40.
9. Murali-Krishna K, Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J Immunol 2000; 165:1733-7.
10. Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 2000; 192:557-64.
11. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98:8732-7.
12. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-32.
13. + T cells in vivo by IL-15. Immunity 1998; 8:591-9.
14. + T cells. J Exp Med 2002; 195:1515-22.
15. + T cells. J Immunol 2003; 170:5018-26.
16. + T cells enables preservation of a naive repertoire. J Immunol 1998; 161:5909-17.
17. Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 1996; 88:230-5.
18. + T cells during persistent infection. Blood 2005; 106:558-65.
19. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003; 101:4260-6.
20. + T cells in vitro. Blood 2003; 10:2541-6.
21. Jones CJ, Soley A, Skinner JW et al. Dissociation of telomere dynamics from telomerase activity in human thyroid cancer cells. Exp Cell Res 1998; 240:333-9.
22. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucl Acids Res 1997; 25:2595-7.
23. + T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol 1993; 15:429-37.
24. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-79.
25. + T cells is dispensable for T cell memory. Proc Natl Acad Sci USA 2003; 10:4724-9.
26. Khaled AR, Durum SK. Death and Baxes: mechanisms of lymphotrophic cytokines. Immunol Rev 2003; 193:48-57.
27. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 2000; 165:1191-6.
28. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol 2002; 2:699-706.
29. + T cells in vitro. J Immunol 2005; 174:4019-24.
30. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89:1033-41.
31. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004; 279:29160-6.
32. Rathmell JC, Farkash EA, Gao W, Thompson CB. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001; 167:6869-76.
33. Cookson S, Reen D. IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells. Blood 2003; 102:2195-7.
34. + naive T cell costimulation. J Immunol 1994; 153:5422-32.
35. Krueger A, Fas SC, Baumann S, Krammer PH. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 2003; 193:58-69.
36. Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14:53-66.
37. Macallan DC, Wallace D, Zhang Y et al. Rapid turnover of effector-memory CD4 (+) T cells in healthy humans. J Exp Med 2004; 200:255-60.
38. Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, Strom TB. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001; 7:114-8.
39. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur J Immunol 1996; 26:1235-9.
40. Effros R, Pawelec G. Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol Today 1997; 18:450-4.
41. Alpdogan O, van den Brink MR. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 2005; 26:56-64.